Drug Profile
Pascolizumab
Alternative Names: Anti-IL-4 monoclonal antibody - GlaxoSmithKline; Anti-IL-4 monoclonal antibody - Protein Design Labs; Anti-interleukin-4 monoclonal antibody - GlaxoSmithKline; Anti-interleukin-4 monoclonal antibody - Protein Design Labs; SB 240683Latest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Interleukin 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma